Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Novel PSMA2 and C7orf25 readthrough (None established)
- Target
- None established
- Molecular classification
- Other (readthrough/fusion transcript, not a conventional protein family)
01
Overview
The ENSG00000256646 gene represents a readthrough fusion transcript joining sequences from the PSMA2 (Proteasome 20S subunit alpha 2) and C7orf25 genes. It is annotated as a protein-coding locus in genomic databases, but its protein product, functional significance, and disease associations are not established. The canonical gene PSMA2 encodes a proteasome subunit involved in protein degradation and is broadly expressed and studied, but the readthrough/fusion gene itself lacks characterization, experimental validation, and clinical relevance.
- Other names
- Novel PSMA2 and C7orf25 readthroughENSG00000256646AC010132.3A0A024RA52A0A7I2V2H3A0A7I2YQP7H3BT36
02
Mechanism of action
None established; no drugs known to interact
03
Biological functions
No well-established biological functions; insufficient evidence for a defined role
04
Disease associations
Currently unknown; no confirmed link to any disease role or pathology
05
Safety considerations
Not applicable; no therapeutic relevance
06
Interacting drugs
None reported
07
Biomarkers
None established
Beyond the preview
Go deeper on Novel PSMA2 and C7orf25 readthrough (None established).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Novel PSMA2 and C7orf25 readthrough (None established).